Finance

Lists
NXTCL:STO
NextCell Pharma AB
SEK 1.04
-5.45%
(-0.060) 1D
Sep 4, 5:18:34 PM GMT+2  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for NXTCL...
Open
SEK 1.10
High
SEK 1.10
Low
SEK 1.03
Mkt. cap
131.21M
Avg. vol.
315.06K
Volume
858.82K
52-wk high
SEK 1.78
52-wk low
SEK 0.63
EPS
-SEK 0.50
Shares outstanding
111.39M
No. of employees
21
Open
SEK 1.10
High
SEK 1.10
Low
SEK 1.03
Mkt. cap
131.21M
Avg. vol.
315.06K
Volume
858.82K
52-wk high
SEK 1.78
52-wk low
SEK 0.63
EPS
-SEK 0.50
Shares outstanding
111.39M
No. of employees
21
About NextCell Pharma AB
CEOMathias Svahn
Employees21
Founded2014
Headquarters-
SectorBiotechnology
Websitenextcellpharma.com
Previous reportsAll values in SEK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in SEK
May 2025
Aug 2025
Mar 2026
Jun 2026
Revenue
2.26M
1.83M
2.78M
3.03M
Cost of goods sold
2.11M
1.93M
1.82M
1.90M
Cost of revenue
2.11M
2.20M
1.82M
1.90M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
9.69M
13.20M
10.88M
12.21M
Operating expense
10.50M
9.11M
11.43M
12.86M
Total operating expenses
12.62M
15.72M
13.25M
14.76M
Operating income
-10.35M
-13.90M
-10.46M
-11.73M
Other non operating income
-
-1.00
-
-
EBT including unusual items
-10.27M
-13.79M
-10.39M
-11.68M
EBT excluding unusual items
-10.27M
-13.79M
-10.39M
-11.68M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
201.47K
-120.48K
-81.33K
37.36K
Net income
-10.27M
-13.79M
-10.39M
-11.68M
Net profit margin
-454.15%
-342.26%
-373.25%
-384.77%
Earnings per share
-
-
-
-
Interest and investment income
82.25K
162.24K
79.47K
50.96K
Interest expense
-
-1.59K
-1.19K
-188.00
Net interest expenses
82.25K
109.02K
78.28K
50.78K
Depreciation and amortization charges
615.41K
638.32K
625.24K
616.94K
EBITDA
-9.74M
-13.26M
-9.84M
-11.11M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps